Skip to main content
. 2019 Feb 5;10(11):1209–1216. doi: 10.18632/oncotarget.26632

Table 2. Toxicity profile.

Grade 1-2 Grade 3-4
TaxAC % TC % OR p TaxAC % TC % OR p
Neutropenia 5.69 5.02 0.41 28.24 28.98 0.48
Anemia 28.56 23.42 1.3 0.001 1.34 0.87 0.12
Thrombocytopenia 5.63 3.14 1.8 0.001 1.84 0.29 6.4 <0.001
Leucopenia 1.82 2.73 0.14 24.31 21.12 1.2 0.002
Febrile Neutropenia 0.06 0.20 0.32 4.64 5.84 0.74 0.005
Nausea 21.77 14.25 1.7 <0.001 3.10 1.19 2.6 <0.001
Vomiting 10.37 4.41 2.5 <0.001 1.96 0.89 2.2 <0.001
Diarrhea 13.22 9.03 1.5 <0.001 2.87 2.78 0.8
Mucositis 7.32 5.02 1.6 0.003 2.44 0.89 2.8 <0.001
Constipation 4.20 5.28 0.16 0.33 0.13 0.25
Allergy 3.45 4.75 0.07 0.67 1.90 0.35 <0.001
Rash 3.73 10.44 0.33 <0.001 0.67 1.61 0.4 0.002
Skin toxicity 2.64 3.88 0.67 0.058 0.13 0.66 0.2 0.02
Hand/Foot syndrome 0.67 1.33 0.7 1.23 0.66 1.9 0.013
Nail toxicity 3.12 3.94 0.2 0.06 0.13 0.5
Conjuctivitis 0.81 0.87 0.86 0 0 n/a n/a
Edema 3.93 4.55 0.4 0.27 0.33 0.7
Fatigue 27.61 24.02 1.2 0.026 5.26 3.17 1.7 <0.001
Neurotoxicity 5.08 5.08 0.99 2.67 1.53 1.8 0.001
Infection 5.92 3.50 1.7 0.006 4.27 4.22 0.9
Arthralgia/myalgia 10.27 16.23 0.59 <0.001 2.85 2.47 0.3
Pain 11.75 12.56 0.5 3.96 3.03 1.3 0.04
Cardiotoxicity 0.88 1.07 0.6 0.75 0.33 2.28 0.015

Abbreviations: OR = odds ratio, TC = taxane & cyclophosphamide, TaxAC = taxane & cyclophosphamide & anthracycline.